Abstract
This review presents the data on the relationship between estrogen and estrogen plus progestin therapy in postmenopausal women and the occurrence of neoplasia in the endometrium, ovary, and uterine cervix. Estrogen only in women with an intact uterus consistently is shown to increase the incidence of endometrial cancer. Estrogen plus a cyclic or sequential progestin reduces the incidence of endometrial cancer to that found in never users. The duration of the progestin administration appears to be important with less than 10 d of progestin having an increased incidence of cancer after 5 yr of therapy. Continuous estrogen plus progestin does not increase the incidence of endometrial cancer. Estrogen and estrogen plus progestin effects on the occurrence of ovarian cancer are inconsistent. The data suggest a possible increase in ovarian epithelial tumors with >10 years use of estrogen only. There is no evidence of a change in the incidence of uterine cervical neoplasia with either estrogen or progestin.
Similar content being viewed by others
References
Yasui, T., Uemura, H., Takikawa, M., and Irahara, M. (2003). J. Med. Invest. 50, 136–145.
Lobo, R. A., Bush, T., Carr, B. R., and Pickar, J. H. (2001). Fertil. Steril. 76, 13–24.
Lindsay, R., Gallagher, J. C., Kleerekoper, M., and Pickar, J. H. (2002). JAMA 287, 2668–2676.
Utian, W. H., Shoupe, D., Bachmann, G., Pinkerton, J. V., and Pickar, J. H. (2001). Fertil. Steril. 75, 1065–1079.
Grodstein, F., Clarkson, T. B., and Manson, J. E. (2003). N. Engl. J. Med. 348, 645–650.
Stampfer, M. J., Colditz, G. A., Willett, W. C., et al. (1991). N. Engl. J. Med. 325, 756–762.
Hadjidakis, D., Kokkinakis, E., Sfakianakis, M., and Raptis, S. A. (1999). Eur. J. Clin. Invest. 29, 877–885.
Yildiz, A., Sahin, I., Gol, K., Taner, Z., Uluturk, A., and Biberoglu, K. (1996). Int. J. Gynaecol. Obstet. 55, 153–159.
Mirkin, S., Navarro, F., and Archer, D. F. (2003). Climacteric 6, 273–277.
Smith, D. C., Prentice, R., Thompson, D. J., and Herrmann, W. L. (1975). N. Engl. J. Med. 293, 1164–1167.
Ziel, H. K. and Finkle, W. D. (1975). N. Engl. J. Med. 293, 1167–1170.
Weiss, N. S. (1978). Ann. Intern. Med. 88, 410–412.
Weiss, N. S., Szekely, D. R., English, D. R., and Schweid, A. I. (1979). JAMA 242, 261–264.
Hulka, B. S. (1997). Prog. Clin. Biol. Res. 396, 17–29.
Archer, D. F. (2001). Menopause 8, 245–251.
Pickar, J. H., Thorneycroft, I., and Whitehead, M. (1998). Am. J. Obstet. Gynecol. 178, 1087–1099.
Weiderpass, E., Baron, J. A., Adami, H. O., et al. (1999). Lancet 353, 1824–1828.
Persson, I., Weiderpass, E., Bergkvist, L., Bergstrom, R., and Schairer, C. (1999). Cancer Causes Control 10, 253–260.
Beresford, S. A., Weiss, N. S., Voigt, L. F., and McKnight, B. (1997). Lancet 349, 458–461.
Woodruff, J. D. and Pickar, J. H. (1994). Am. J. Obstet. Gynecol. 170, 1213–1223.
Pickar, J. H., Yeh, I. T., Wheeler, J. E., Cunnane, M. F., and Speroff, L. (2003). Fertil. Steril. 80, 1234–1240.
Pickar, J. H., Yeh, I., Wheeler, J. E., Cunnane, M. F., and Speroff, L. (2001). Fertil. Steril. 76, 25–31.
Staland, B. (1985). Acta Obstet. Gynecol. Scand. Suppl. 130, 29–35.
Staland, B. (1981). Maturitas 3, 145–56.
Archer, D. F., Dorin, M., Lewis, V., Schneider, D. L., and Pickar, J. H. (2001). Fertil. Steril. 75, 1080–1087.
Archer, D. F., Pickar, J. H., and Bottiglioni, F. (1994). Obstet. Gynecol. 83, 686–692.
Simon, J. A., Liu, J. H., Speroff, L., Shumel, B. S., and Symons, J. P. (2003). Am. J. Obstet. Gynecol. 188, 92–99.
Williams, S. R., Frenchek, B., Speroff, T., and Speroff, L. (1990). Am. J. Obstet. Gynecol. 162, 438–446.
Speroff, L., Rowan, J., Symons, J., Genant, H., and Wilborn W. (1996). JAMA 276, 1397–1403.
Symons, J., Kempfert, N., and Speroff, L. (2000). Obstet. Gynecol. 96, 366–372.
Hill, D. A., Weiss, N. S., Beresford, S. A., et al. (2000). Am. J. Obstet. Gynecol. 183, 1456–1461.
Role of progestogen in hormone therapy for postmenopausal women, position statement of The North American Menopause Society. (2003). Menopause 10, 113–132.
Kurman, R. J., Felix, J. C., Archer, D. F., Nanavati, N., Arce, J., and Moyer, D. L. (2000). Obstet. Gynecol. 96, 373–379.
Archer, D. F., Furst, K., Tipping, D., Dain, M. P., and Vandepolc C. (1999). Obstet. Gynecol. 94, 498–503.
The Writing Group for the PEPI Trial. (1996). JAMA 275, 370–375.
Kurman, R. J., Kaminski, P. F., and Norris, H. J. (1985). Cancer 56, 403–412.
Ferenczy, A. and Gelfand, M. (1989). Am. J. Obstet. Gynecol. 160, 126–131.
Austin, H., Austin, J. M. Jr., Partridge, E. E., Hatch, K. D., and Shingleton, H. M. (1991). Cancer Res. 51, 568–572.
Deslypere, J. P. (1995). Metabolism 44, 24–27.
Purdie, D. M. and Green, A. C. (2001). Best Pract. Res. Clin. Obstet. Gynaecol. 15, 341–354.
Kaaks, R., Lukanova, A., and Kurzer, M. S. (2002). Cancer Epidemiol. Biomarkers Prev. 11, 1531–1543.
Salazar-Martinez, E., Lazcano-Ponce, E. C., Lira-Lira, G. G., et al. (2000). Cancer Causes Control 11, 707–711.
Zendehdel, K., Nyren, O., Ostenson, C. G., Adami, H. O., Ekbom, A., and Ye, W. (2003). J. Natl. Cancer Inst. 95, 1797–1800.
Folsom, A. R., Demissie, Z., and Harnack, L. (2003). Nutr. Cancer 46, 119–124.
Legro, R. S. (2002). Minerva Ginecol. 54, 97–114.
Norman, R. J. and McVeigh, E. (1999). Climacteric 2, 141–143.
Rossouw, J. E., Anderson, G. L., Prentice, R. L., et al. (2002). JAMA 288, 321–333.
Cushing, K. L., Weiss, N. S., Voigt, L. F., McKnight, B., and Beresford, S. A. (1998). Obstet. Gynecol. 91, 35–39.
Ettinger, B., Selby, J., Citron, J. T., Vangessel, A., Ettinger, V. M., and Hendrickson, M. R. (1994). Obstet. Gynecol. 83, 693–700.
Ettinger, B., Pressman, A., and Van Gessel, A. (2001). Obstet. Gynecol. 98, 205–211.
Boerrigter, P. J., van de Weijer, P. H., Baak, J. P., Fox, H., and Haspels, A. A. (1996). Maturitas 24, 63–71.
Bjarnason, K., Cerin, A., Lindgren, R., and Weber, T. (1999). Maturitas 32, 161–170.
Cohen, L. and Fishman, D. A. (2002). Cancer Treat Res. 107, 119–132.
NIH Consensus Development Panel on Ovarian Cancer. (1995). JAMA 273, 491–497.
van Nagell, J. R. Jr., DePriest, P. D., Reedy, M. B., et al. (2000). Gynecol. Oncol. 77, 350–356.
Tailor, A., Bourne, T. H., Campbell, S., Okokon, E., Dew, T., and Collins, W. P. (2003). Ultrasound Obstet. Gynecol. 21, 378–385.
Garg, P. P., Kerlikowske, K., Subak, L., and Grady, D. (1998). Obstet. Gynecol. 92, 472–479.
Coughlin, S. S., Giustozzi, A., Smith, S. J., and Lee, N. C. (2000). J. Clin. Epidemiol. 53, 367–375.
Lacey, J. V. Jr., Mink, P. J., Lubin, J. H., et al. (2002). JAMA 288, 334–341.
Hartge, P., Hoover, R., McGowan, L., Lesher, L., and Norris, H. J. (1988). Am. J. Epidemiol. 127, 990–998.
Riman, T., Dickman, P. W., Nilsson, S., et al. (2002). J. Natl. Cancer Inst. 94, 497–504.
Lacey, J. V. Jr., Sherman, M. E., Hartge, P., Schatzkin, A., and Schairer, C. (2004). Int. J. Cancer 108, 281–286.
Rodriguez, C., Patel, A. V., Calle, E. E., Jacob, E. J., and Thun, M. J. (2001). JAMA 285, 1460–1465.
Persson, I., Yuen, J., Bergkvist, L., and Schairer, C. (1996). Int. J. Cancer 67, 327–332.
Smith, E. M., Johnson, S. R., Figuerres, E. J., et al. (1997). Gynecol. Oncol. 65, 441–446.
Adami, H. O., Persson, I., Hoover, R., Schairer, C., and Bergkvist, L. (1989). Int. J. Cancer 44, 833–839.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Archer, D.F. Neoplasia of the female reproductive tract. Endocr 24, 259–263 (2004). https://doi.org/10.1385/ENDO:24:3:259
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:24:3:259